NASDAQ:SIBN - SI-Bone Stock Price, News & Analysis

$19.80
+0.26 (+1.33 %)
(As of 09/19/2019 02:50 AM ET)
Today's Range
$19.35
Now: $19.80
$19.99
50-Day Range
$16.60
MA: $19.00
$20.19
52-Week Range
$14.08
Now: $19.80
$23.03
Volume81,050 shs
Average Volume121,619 shs
Market Capitalization$486.29 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
SI-BONE, Inc., a medical device company, develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. It offers iFuse, an implant system to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that causes lower back pain. The company was founded in 2008 and is headquartered in Santa Clara, California.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:SIBN
CUSIPN/A
CIKN/A
Phone408-207-0700

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$55.38 million
Book Value$3.71 per share

Profitability

Net Income$-17,450,000.00

Miscellaneous

Employees183
Market Cap$486.29 million
Next Earnings Date12/5/2019 (Estimated)
OptionableNot Optionable

Receive SIBN News and Ratings via Email

Sign-up to receive the latest news and ratings for SIBN and its competitors with MarketBeat's FREE daily newsletter.


SI-Bone (NASDAQ:SIBN) Frequently Asked Questions

What is SI-Bone's stock symbol?

SI-Bone trades on the NASDAQ under the ticker symbol "SIBN."

How were SI-Bone's earnings last quarter?

SI-Bone Inc (NASDAQ:SIBN) posted its earnings results on Tuesday, August, 6th. The company reported ($0.35) earnings per share for the quarter, beating analysts' consensus estimates of ($0.40) by $0.05. The firm earned $16.32 million during the quarter. SI-Bone had a negative net margin of 46.59% and a negative return on equity of 84.84%. View SI-Bone's Earnings History.

When is SI-Bone's next earnings date?

SI-Bone is scheduled to release their next quarterly earnings announcement on Thursday, December 5th 2019. View Earnings Estimates for SI-Bone.

What guidance has SI-Bone issued on next quarter's earnings?

SI-Bone updated its FY 2019 earnings guidance on Tuesday, August, 6th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $65-66.5 million, compared to the consensus revenue estimate of $65.9 million.

What price target have analysts set for SIBN?

4 equities research analysts have issued 12-month target prices for SI-Bone's shares. Their forecasts range from $23.00 to $27.00. On average, they anticipate SI-Bone's stock price to reach $24.75 in the next year. This suggests a possible upside of 25.0% from the stock's current price. View Analyst Price Targets for SI-Bone.

What is the consensus analysts' recommendation for SI-Bone?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for SI-Bone in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for SI-Bone.

Has SI-Bone been receiving favorable news coverage?

News coverage about SIBN stock has been trending negative recently, according to InfoTrie Sentiment. InfoTrie rates the sentiment of media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. SI-Bone earned a media sentiment score of -2.9 on InfoTrie's scale. They also gave media stories about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the company's share price in the next several days. View News Stories for SI-Bone.

Are investors shorting SI-Bone?

SI-Bone saw a decrease in short interest in August. As of August 15th, there was short interest totalling 721,300 shares, a decrease of 10.9% from the July 15th total of 809,200 shares. Based on an average daily trading volume, of 160,900 shares, the days-to-cover ratio is currently 4.5 days. Approximately 5.0% of the company's stock are short sold. View SI-Bone's Current Options Chain.

Who are some of SI-Bone's key competitors?

What other stocks do shareholders of SI-Bone own?

Who are SI-Bone's key executives?

SI-Bone's management team includes the folowing people:
  • Mr. Jeffrey W. Dunn, CEO, Pres & Chairman (Age 63)
  • Dr. Mark A. Reiley M.D., Founder & Director (Age 68)
  • Ms. Laura A. Francis, Chief Financial Officer (Age 52)
  • Mr. Anthony J. Recupero, Chief Commercial Officer (Age 61)
  • Dr. Scott A. Yerby, Chief Technology Officer (Age 51)

When did SI-Bone IPO?

(SIBN) raised $84 million in an initial public offering (IPO) on Wednesday, October 17th 2018. The company issued 6,000,000 shares at a price of $13.00-$15.00 per share. Morgan Stanley and BofA Merrill Lynch served as the underwriters for the IPO and Canaccord Genuity and JMP Securities were co-managers.

Who are SI-Bone's major shareholders?

SI-Bone's stock is owned by a number of of institutional and retail investors. Top institutional investors include BlackRock Inc. (4.56%), First Light Asset Management LLC (2.65%), Vanguard Group Inc. (2.29%), Wells Fargo & Company MN (1.90%), Meridian Investment Counsel Inc. (1.56%) and Price T Rowe Associates Inc. MD (1.23%). Company insiders that own SI-Bone stock include Anthony J Recupero, David P Bonita, Jeffrey W Dunn, Laura Francis, Mark A Reiley, Michael A Pisetsky, Scott A Yerby, Skyline Venture Partners V Lp and W Carlton Reckling. View Institutional Ownership Trends for SI-Bone.

Which institutional investors are selling SI-Bone stock?

SIBN stock was sold by a variety of institutional investors in the last quarter, including Price T Rowe Associates Inc. MD, JPMorgan Chase & Co. and Granite Investment Partners LLC. Company insiders that have sold SI-Bone company stock in the last year include Anthony J Recupero, Jeffrey W Dunn, Laura Francis, Mark A Reiley, Michael A Pisetsky, Scott A Yerby, Skyline Venture Partners V Lp and W Carlton Reckling. View Insider Buying and Selling for SI-Bone.

Which institutional investors are buying SI-Bone stock?

SIBN stock was acquired by a variety of institutional investors in the last quarter, including First Light Asset Management LLC, BlackRock Inc., Meridian Investment Counsel Inc., Capital Bank & Trust Co, Vanguard Group Inc., Nine Ten Capital Management LLC, Commonwealth Equity Services LLC and Morgan Stanley. Company insiders that have bought SI-Bone stock in the last two years include David P Bonita and Skyline Venture Partners V Lp. View Insider Buying and Selling for SI-Bone.

How do I buy shares of SI-Bone?

Shares of SIBN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is SI-Bone's stock price today?

One share of SIBN stock can currently be purchased for approximately $19.80.

How big of a company is SI-Bone?

SI-Bone has a market capitalization of $486.29 million and generates $55.38 million in revenue each year. The company earns $-17,450,000.00 in net income (profit) each year or ($0.71) on an earnings per share basis. SI-Bone employs 183 workers across the globe.View Additional Information About SI-Bone.

What is SI-Bone's official website?

The official website for SI-Bone is http://si-bone.com/.

How can I contact SI-Bone?

SI-Bone's mailing address is 471 EL CAMINO REAL SUITE 101, SANTA CLARA CA, 95050. The company can be reached via phone at 408-207-0700 or via email at [email protected]


MarketBeat Community Rating for SI-Bone (NASDAQ SIBN)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  34 (Vote Outperform)
Underperform Votes:  49 (Vote Underperform)
Total Votes:  83
MarketBeat's community ratings are surveys of what our community members think about SI-Bone and other stocks. Vote "Outperform" if you believe SIBN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SIBN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/19/2019 by MarketBeat.com Staff

Featured Article: Quantitative Easing

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel